Biomedical Investigations of Pharmacology and Pathology

药理学和病理学的生物医学研究

• 批准号: nhmrc : GNT1062607
• 负责人: Prof Des Richardson
• 金额: $ 82.29万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/biomedical-investigations-pharmacology-pathology/1344816
• 关键词: Biomedical; Investigations; Pharmacology; Pathology

I am an NHMRC SPRF & Director of the Molecular Pharmacology & Pathology Program consisting of 34 researchers. The breadth of our studies is diverse & continues to expand. Excitingly, we have recently obtained commercialisation support to develop our anti-tumour drug, DpC. My vision for the next 5 yrs is to direct development of these agents together with investigations of basic mechanism. These studies will be done with a team of outstanding researchers I am mentoring and an established group of experienced collaborators.

我是NHMRC SPRF和分子药理学和病理学项目的主任，由34名研究人员组成。我们的研究的广度是多样化的，并继续扩大。令人兴奋的是，我们最近获得了开发抗肿瘤药物DpC的商业化支持。我对未来5年的愿景是指导这些药物的开发以及基本机制的研究。这些研究将与我指导的一组杰出研究人员和一组经验丰富的合作者一起完成。